Europäische Union - Deutsch - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - irbesartan, hydrochlorothiazid - hypertonie - wirkstoffe, die auf das renin-angiotensin-system einwirken - behandlung von essentieller hypertonie. diese fixe dosis-kombination ist indiziert bei erwachsenen patienten, deren blutdruck nicht ausreichend kontrolliert auf irbesartan oder hydrochlorothiazid allein (siehe abschnitt 5.

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - irbesartanum, hydrochlorothiazidum - filmtabletten - irbesartanum 150 mg, hydrochlorothiazidum 12.5 mg, lactosum monohydricum 38.5 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. hypromellosum, silica colloidalis anhydrica, magnesii stearas, pellicule: lactosum monohydricum 3.6 mg, hypromellosum, e 171, macrogolum 3000, e 172 (flavum), e 172 (rubrum), cera carnauba, pro compresso obducto corresp. natrium 1.09281 mg. - hypertonie essentiell - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - irbesartanum, hydrochlorothiazidum - filmtabletten - irbesartanum 300 mg, hydrochlorothiazidum 12.5 mg, lactosum monohydricum 89.5 mg, cellulosum microcristallinum, carmellosum natricum conexum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, pellicule: lactosum monohydricum 7.2 mg, hypromellosum, e 171, macrogolum 3000, e 172 (flavum), e 172 (rubrum), cera carnauba, pro compresso obducto corresp. natrium 2.18562 mg. - hypertonie essentiell - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - irbesartanum, hydrochlorothiazidum - filmtabletten - irbesartanum 300 mg, hydrochlorothiazidum 25 mg, lactosum monohydricum 53.3 mg, cellulosum microcristallinum, carmellosum natricum conexum, amylum pregelificatum, e 172 (rubrum), e 172 (flavum), magnesii stearas, silica colloidalis anhydrica, pellicule: lactosum monohydricum 7.56 mg, hypromellosum, e 171, macrogolum 3350, e 172 (rubrum), e 172 (nigrum), cera carnauba, pro compresso obducto corresp. natrium 2.7345 mg. - hypertonie essentiell - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - irbesartanum, hydrochlorothiazidum - filmtabletten - irbesartanum 150.0 mg, hydrochlorothiazidum 12.5 mg, povidonum, amylum pregelificatum, poloxamerum 188, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.75 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, e 171, macrogolum 6000, macrogolum 400, e 172 (rubrum), e 172 (flavum), e 172 (nigrum), pro compresso obducto. - hypertonie essentiell - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - irbesartanum, hydrochlorothiazidum - filmtabletten - irbesartanum 300.0 mg, hydrochlorothiazidum 12.5 mg, povidonum, amylum pregelificatum, poloxamerum 188, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 1.51 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, e 171, macrogolum 6000, macrogolum 400, e 172 (rubrum), e 172 (flavum), e 172 (nigrum), pro compresso obducto. - hypertonie essentiell - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - irbesartanum, hydrochlorothiazidum - filmtabletten - irbesartanum 300.0 mg, hydrochlorothiazidum 25.0 mg, povidonum, amylum pregelificatum, poloxamerum 188, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 1.51 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, e 171, macrogolum 6000, macrogolum 400, e 172 (rubrum), e 132, e 172 (nigrum), pro compresso obducto. - hypertonie essentiell - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - irbesartanum, hydrochlorothiazidum - filmtabletten - irbesartanum 150 mg, hydrochlorothiazidum 12.5 mg, lactosum monohydricum 38.5 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: lactosum monohydricum 3.6 mg, hypromellosum, e 171, macrogolum 3000, e 172 (flavum), e 172 (rubrum), cera carnauba, pro compresso obducto corresp. natrium 1.09281 mg. - essentielle hypertonie - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - irbesartanum, hydrochlorothiazidum - filmtabletten - irbesartanum 300 mg, hydrochlorothiazidum 12.5 mg, lactosum monohydricum 89.5 mg, cellulosum microcristallinum, carmellosum natricum conexum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: lactosum monohydricum 7.2 mg, hypromellosum, e 171, macrogolum 3000, e 172 (flavum), e 172 (rubrum), cera carnauba, pro compresso obducto corresp. natrium 2.18562 mg. - essentielle hypertonie - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - irbesartanum, hydrochlorothiazidum - filmtabletten - irbesartanum 300 mg, hydrochlorothiazidum 25 mg, lactosum monohydricum 53.3 mg, cellulosum microcristallinum, carmellosum natricum conexum, amylum pregelificatum, e 172 (rubrum), e 172 (flavum), magnesii stearas, silica colloidalis anhydrica, Überzug: lactosum monohydricum 7.56 mg, hypromellosum, e 171, macrogolum 3350, e 172 (rubrum), e 172 (nigrum), cera carnauba, pro compresso obducto corresp. natrium 2.7345 mg. - essentielle hypertonie - synthetika